Pattern of AMP Degradation in Ischemic Rabbit Lung Tissue

References

• Von Reinhard F. M., Busch E-W. Abbau der Purinnucleotide in Ischamischen Gehirn- und Muskelgeweben von Kaninchen. Hoppe-Seylers Z Physiol Chem. 1969; 350: 1410–1414
   Google Scholar
• Rubio R., Berne R. M., Dobson J. G. Sites of adenosine production in cardiac and skeletal muscle. Am J Physiol. 1973; 225(4)938–953
   PubMedGoogle Scholar
• Van den Berghe G., Bontemps F., Hers H-G. Purine catabolism in isolated rat hepatocytes. Influence of coformycin. Biochem J. 1980; 188: 913–920
   Google Scholar
• Van den Berghe G., Vincent M. F., Bontemps F. Pathways and control of adenine nucleotide catabolism in anoxic rat hepatocytes. Biomed Biochim Acta. 1989; 48: 5–10
   Google Scholar
• Richman H. G., Wyborny L. Adenine nucleotide degradation in the rabbit heart. Am J Physiol. 1964; 207(5)1, 139–1145
   Google Scholar
• Osswald H., Schmitz H-J, Kemper R. Tissue content of adenosine, inosine and hypoxanthine in the rat kidney after ischemia and postischemic recirculation. Pflügers Arch. 1977; 371: 45–49
   Google Scholar
• Kleihues P., Kobayashi F., Hossmann K-A. Purine nucleotide metabolism in the cat brain after one hour of complete ischemia. J Neurochem. 1974; 23: 417–425
   Google Scholar
• Foker J. E., Einzig S., Wang T. Adenosine metabolism and myocardial preservation. Consequences of adenosine catabolism on myocardial high-energy compounds and tissue blood flow. J Thorac Cardiovasc Surg. 1980; 80: 506–516
   PubMedGoogle Scholar
• Humphrey S. M., Seelye R. N. Improved functional recovery of ischemic myocardium by suppression of adenosine catabolism. J Thorac Cardiovasc Surg. 1982; 84: 16–22
   PubMed Web of Science ®Google Scholar
• Bolling S. F., Bles L. E., Bove E. L., Gallagher K. P. Augmenting intracellular adenosine improves myocardial recovery. J Thorac Cardiovasc Surg. 1990; 99: 469–474
   Google Scholar
• Flameng W., Sukehiro S., Möllhoff T., van Belle H., Janssen P. A new concept of long-term donor heart preservation; nucleoside transport inhibition. J Heart Lung Transplant. 1991; 10: 990–998
   PubMed Web of Science ®Google Scholar
• Granger D. N. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol. 1988; 255: H1269–H1275
   PubMed Web of Science ®Google Scholar
• Linas S. L., Whittenburg D., Repine J. E. Role of xanthine oxidase in ischemia/reperfusion injury. Am J Physiol. 1990; 258: F711–F716
   PubMedGoogle Scholar
• Terada L. S., Rubinstein J. D., Lesnefsky E. J., Horwitz L. D., Leff J. A., Repine J. E. Existence and participation of xanthine oxidase in reperfusion injury of ischemic rabbit myocardium. Am J Physiol. 1991; 260: H805–H810
   Google Scholar
• Grosso M. A., Brown J. M., Viders D. E., et al. Xanthine oxidase-derived oxygen radicals induce pulmonary edema via direct endothelial cell injury. J Surg Res. 1989; 46: 355–360
   PubMed Web of Science ®Google Scholar
• Lynch M. J., Grum C. M., Gallagher K. P., Bolling S. F., Deeb G. M., Morganroth M. L. Xanthine oxidase inhibition attenuates ischemic-reperfusion lung injury. J Surg Res. 1988; 44: 538–544
   PubMed Web of Science ®Google Scholar
• Kennedy T. P., Rao N. V., Hopkins C., Pennington L., Tolley E., Hoidal J. R. Role of reactive oxygen species in reperfusion injury of the rabbit lung. J Clin Invest. 1989; 83: 1326–1335
   PubMed Web of Science ®Google Scholar
• Adkins W. K., Taylor A. E. Role of xanthine oxidase and neutrophils in ischemia-reperfusion injury in rabbit lung. J Appl Physiol. 1990; 69(6)2012–2018
   PubMed Web of Science ®Google Scholar
• Kjaeve J., Veel T., Bjertnaes L. Allopurinol inhibits hypoxic pulmonary vasoconstriction. Role of toxic oxygen metabolites. Acta Anaesrtiesiol Scand. 1990; 34: 384–388
   Google Scholar
• Qayumi A. K., Jamieson W. RE, Godin D. V., et al. Response to allopurinol pretreatment in a swine model of heart-lung transplantation. J Invest Surg. 1990; 3: 331–340
   PubMedGoogle Scholar
• Wynants J., van Belle H. Single-run high-performance liquid chromatography of nucleotides, nucleosides, and major purine bases and its application to different tissue extracts. Anal. Biochem. 1985; 144: 256–266
   Google Scholar
• Scheffe H. A method for judging all contrast in the analysis of variance. Biometrika. 1953; 40: 87–104
   Web of Science ®Google Scholar
• von Wichert P. Studies on the metabolism of ischemic rabbit lungs. J Thorac Cardiovasc Surg. 1972; 63: 284–291
   Google Scholar
• Hall T. S., Buescher P. C., Borkon A. M., Reitz B. A., Michael J. R., Baumgartner W. A. 31P Nuclear magnetic resonance determination of changes in energy state in lung preservation. Circulation 1988; 78(suppl. 3)95–98
   Google Scholar
• Berne R. M., Rubio R. Adenine nucleotide metabolism in the heart. Circ Res. 1974; 34–35((suppl. 3))109–120
   Google Scholar
• Agarwal R. P., Spector T., Parks R. E. Tight-binding inhibitor IV: inhibition of adenosine deaminases by various inhibitors. Biochem Pharmacol. 1977; 26: 359–367
   PubMed Web of Science ®Google Scholar
• Henderson J. F., Brox L., Zombor G., Hunting D., Lomax C. A. Specificity of adenosine deaminase inhibitors. Biochem Phartnacol. 1977; 26: 1967–1972
   PubMed Web of Science ®Google Scholar
• van Belle H. Molecular purines during ischemia, reperfusion and pharmacological protection. Mol Physiol. 1985; 8: 615–630
   Google Scholar
• Belardinelli L., Linden J., Berne R. M. The cardiac effects of adenosine. Prog Cardiovasc Dis. 1989; 32: 73–97
   PubMed Web of Science ®Google Scholar
• Flameng W., Xhonneux R., Vanhaecke J., Van de Water A., Suy M. Prevention of “no-reflow” phenomenon in the canine heart by mioflazine. Basic Res Cardiol. 1985; 80: 27–36
   Google Scholar
• Olafson B., Forman M. B., Puett D. W., et al. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenom. Circulation 1987; 76: 1135–1145
   Google Scholar
• Babbitt D. B., Virmani R., Forman M. B. Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model. Circulation 1989; 80: 1388–1399
   PubMed Web of Science ®Google Scholar
• Abd-Elfattah A. S., Jessen M. E., Lekven J., Doherty N. E., Brunsting L. A., Wechsler A. S. Myocardial reperfusion injury. Role of myocardial hypoxanthine and xanthine in free radical-mediated reperfusion injury. Circulation 1988; 78(suppl. 3)224–235
   Google Scholar
• Mentzer R. M., Rubio R., Berne R. M. Release of adenosine by hypoxic canine lung tissue and its possible role in pulmonary circulation. Am J Physiol. 1975; 229(6)1625–1631
   Google Scholar
• Reld P. G., Fraser A. G., Watt A. H., Henderson A. H., Routledge P. A. Acute haemodynamic effects of intravenous infusion of adenosine in conscious man. Europ Heart J. 1990; 11: 1018–1028
   Google Scholar
• Roepke J. E., Patterson C. E., Packer C. S., Rhoades R. A. Response of perfused lung and isolated pulmonary artery to adenosine. Exp Lung Res. 1991; 17: 25–37
   PubMed Web of Science ®Google Scholar
• Cronstein B. N., Levin R. I., Belanoff J., Weissmann G., Hirschhom R. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin Invest. 1986; 78: 760–770
   PubMed Web of Science ®Google Scholar
• McCord J. M. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985; 312: 159–163
   PubMed Web of Science ®Google Scholar
• Jarasch E. D., Bruder G., Held H. W. Significance of xanthine oxidase in capillary endothelial cells. Acta Physiol Scand. 1986; 548: 39–46
   Google Scholar
• Tate R. M., Vanbenthuysen K. M., Shasby D. M., McMurtry I. F., Repine J. E. Oxygen-radical-mediated permeability edema and vasoconstriction in isolated perfused rabbit lungs. Am Rev Respir Dis. 1982; 126302–806
   Google Scholar